Want to see HK:1358 full AI Analyst Report?
PW Medtech Group Ltd. (1358) Stock Statistics & Valuation Metrics
Total Valuation
PW Medtech Group Ltd. has a market cap or net worth of HKD 1.28B. The enterprise value is HKD 506.82M.
- Market Cap
- HKD 1.28B
- Enterprise Value
- HKD 506.82M
Share Statistics
PW Medtech Group Ltd. has 1,433,241,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,433,241,100
- Owned by Insiders
- ―
- Owned by Institutions
- 0.49%
Financial Efficiency
PW Medtech Group Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.99%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.02
- Return on Invested Capital (ROIC)
- 1.99%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 574.67K
- Profits Per Employee
- 65.86K
- Employee Count
- 1,433
- Asset Turnover
- 0.16
- Inventory Turnover
- 2.86
Valuation Ratios
The current PE Ratio of PW Medtech Group Ltd. is 26.50. PW Medtech Group Ltd.’s PEG ratio is -0.38.
- PE Ratio
- 26.50
- PS Ratio
- 1.34
- PB Ratio
- 0.28
- Price to FCF
- 5.67
- Price to Operating Cash Flow
- 4.22
- PEG Ratio
- -0.38
Income Statement
In the last 12 months, PW Medtech Group Ltd. had revenue of 823.50M and earned 94.37M in profits. Earnings per share was 0.06.
- Revenue
- 823.50M
- Gross Profit
- 407.46M
- Operating Income
- 122.30M
- Pretax Income
- 164.99M
- Net Income
- 94.37M
- EBITDA
- 265.57M
- Earnings Per Share (EPS)
- 0.06
Cash Flow
In the last 12 months, operating cash flow was 261.88M and capital expenditures -72.10M, giving a free cash flow of 189.78M billion.
- Operating Cash Flow
- 261.88M
- Free Cash Flow
- 189.78M
- Free Cash Flow per Share
- 0.13
Dividends & Yields
PW Medtech Group Ltd. pays an annual dividend of HKD 0.04, resulting in a dividend yield of 7.15%
- Dividend Per Share
- HKD 0.04
- Dividend Yield
- 7.15%
- Payout Ratio
- 92.38%
- Free Cash Flow Yield
- 17.65%
- Earnings Yield
- 3.90%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- -40.73%
- 50-Day Moving Average
- 0.91
- 200-Day Moving Average
- 1.07
- Relative Strength Index (RSI)
- 47.32
- Average Volume (3m)
- 519.58K
Important Dates
PW Medtech Group Ltd. upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- Nov 03, 2025
Financial Position
PW Medtech Group Ltd. as a current ratio of 10.89, with Debt / Equity ratio of 0.56%
- Current Ratio
- 10.89
- Quick Ratio
- 10.22
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- -6.71
- Interest Coverage Ratio
- 169.86
Taxes
In the past 12 months, PW Medtech Group Ltd. has paid 29.74M in taxes.
- Income Tax
- 29.74M
- Effective Tax Rate
- 0.18
Enterprise Valuation
PW Medtech Group Ltd. EV to EBITDA ratio is -3.36, with an EV/FCF ratio of -3.85.
- EV to Sales
- -0.91
- EV to EBITDA
- -3.36
- EV to Free Cash Flow
- -3.85
- EV to Operating Cash Flow
- -2.79
Balance Sheet
PW Medtech Group Ltd. has HKD 1.83B in cash and marketable securities with HKD 21.03M in debt, giving a net cash position of HKD 1.81B billion.
- Cash & Marketable Securities
- HKD 1.83B
- Total Debt
- HKD 21.03M
- Net Cash
- HKD 1.81B
- Net Cash Per Share
- HKD 1.26
- Tangible Book Value Per Share
- HKD 2.21
Margins
Gross margin is 47.88%, with operating margin of 9.08%, and net profit margin of 5.36%.
- Gross Margin
- 47.88%
- Operating Margin
- 9.08%
- Pretax Margin
- 14.03%
- Net Profit Margin
- 5.36%
- EBITDA Margin
- 27.05%
- EBIT Margin
- 8.99%
Analyst Forecast
The average price target for PW Medtech Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -1.64%
- EPS Growth Forecast
- -68.67%
Scores
- Smart Score
- ―
- AI Score
- 67